Autologous Dendritic Cell

BIOLOGICAL3 trials

Sponsors

Dartmouth-Hitchcock Medical Center, Samsung Medical Center, Chang Gung Memorial Hospital

Conditions

Glioblastoma MultiformeHepatocellular CarcinomaProstatic Cancer

Phase 1

Autologous Dendritic Cell Therapy for Hormone-Refractory Metastatic Prostate Cancer

CompletedNCT01171729

Samsung Medical CenterProstatic Cancer

Start: 2006-07-31End: 2010-05-31Updated: 2010-08-11

Phase 2

Phase II Feasibility Study of Dendritic Cell Vaccination for Newly Diagnosed Glioblastoma Multiforme

CompletedNCT00323115

Dartmouth-Hitchcock Medical CenterGlioblastoma Multiforme

Start: 2006-05-31End: 2013-07-31Updated: 2018-10-10

Dendritic Cell Vaccination to Prevent Hepatocellular Carcinoma Recurrence After Liver Resection-phase II Clinical Trial

Not yet recruitingNCT06193733

Chang Gung Memorial HospitalHepatocellular Carcinoma

Start: 2024-02-19End: 2028-02-29Target: 74Updated: 2024-01-05